miR‐204‐5p suppresses hepatocellular cancer proliferation by regulating homeoprotein SIX1 expression

Fewer than 30% of patients with hepatocellular carcinoma (HCC) are eligible to receive curative therapies, and so a better understanding of the molecular mechanisms of HCC is needed to identify potential therapeutic targets. The role of microRNA (miRNA) in modulating tumour progression has been demo...

Descripción completa

Detalles Bibliográficos
Autores principales: Chu, Yi, Jiang, Mingzuo, Du, Feng, Chen, Di, Ye, Tao, Xu, Bing, Li, Xiaowei, Wang, Weijie, Qiu, Zhaoyan, Liu, Haiming, Nie, Yongzhan, Liang, Jie, Fan, Daiming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5794460/
https://www.ncbi.nlm.nih.gov/pubmed/29435409
http://dx.doi.org/10.1002/2211-5463.12363

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5794460/
https://www.ncbi.nlm.nih.gov/pubmed/29435409
http://dx.doi.org/10.1002/2211-5463.12363

Ejemplares similares